November 6, 2019
Steven Vold, MD, founder and CEO of Vold Vision in Northwest Arkansas, shares how his practice uses intense pulsed light (IPL) therapy to treat dry eye disease (DED) in glaucoma patients, during the 2019 American Academy of Ophthalmology annual meeting in San Francisco.
